Study of usage and outcomes of Polymyxin B in serious Bacterial Infections in Indian patients
Not Applicable
- Conditions
- Health Condition 1: A498- Other bacterial infections of unspecified siteHealth Condition 2: null- patients with management of systemic bacterial infection
- Registration Number
- CTRI/2018/03/012366
- Lead Sponsor
- Wockhardt Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. An Adult ( > 18 years) Indian patient of either gender who is reported to have received at least 1 dose of Polymyxin B for management of systemic bacterial infection
2. Patient provides consent for recording of patient related data from medical records into the registry
Exclusion Criteria
1. Adult less than 18 years of age
2. Patients not received at least 1 dose of Polymyxin B for management of systemic bacterial infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pattern of usage of Polymyxin B in various healthcare setups <br/ ><br>2. Outcomes associated with therapy with Polymyxin B <br/ ><br>Timepoint: 12months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Demographic and disease distribution of usage of Polymyxin B <br/ ><br>Timepoint: 12 months;Incidence of side effects and / or development of abnormal laboratory parametersTimepoint: 12 months